This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Rifampicin (chemoprophylaxis in meningococcal disease)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Rifampicin is the most usually used drug for chemoprophylaxis. Typical dose:

  • 600 mg every 12 hours for 2 days - adults and children over 12 years
  • 10 mg/kg in children aged 1-12 years every 12 hours for 2 days
  • 5 mg/kg in children below one year

Chemoprophylaxis is given to close contacts of the patient (household members, kissing contacts, and friends who have stayed in the patient's home for hours during the past week) to eradicate meningococci. In general, 15% of contacts carry meningococci. However only 3-4% of contacts carry the pathogenic strain (1).

Note that the respective summary of product characteristics must be consulted before prescribing any drug mentioned.

Reference:

  • BMJ editorial (1996). Secondary prevention of meningococccal disease. BMJ, 312, 590-1.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.